Sarah Emmond
President and CEO of the Institute for Clinical and Economic Review, providing expert analysis on cost-effectiveness and value assessments for medicines in the US healthcare system.
Best podcasts with Sarah Emmond
Ranked by the Snipd community
Mar 2, 2026 • 17min
Weight-loss drugs. Who pays?
Sarah Emmond, CEO of the Institute for Clinical and Economic Review, explains how cost‑effectiveness and pricing shape access. Yelena Kibisova, advocate and coach who has used GLP-1 treatment, shares her personal journey and insurance struggles. They discuss GLP-1 drugs' wider health benefits, who pays for them across insurers and employers, coverage limits, and the risks of unequal access.
